Pfizer Inc. news

   Watch this stock
Showing stories 1 - 10 of about 218   

Articles published

PFE 34.26 +0.20 (0.59%)
price chart
Pfizer Prices $1065000000 Debt Offering
NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) today announced the pricing of $1,065,000,000 aggregate principal amount of 4.20% notes due 2047.
Better Buy: Pfizer Inc. vs. Merck & Co. Inc.
One of the top reasons for investors to like Pfizer is its dividend. Pfizer's dividend yield currently stands at 3.81% -- one of the highest of all big pharma stocks.
Is Pfizer's Research Pipeline Truly Undervalued?
I have also given a detailed account of the major cancer drugs in Pfizer's portfolio, considered to be the key growth drivers for the company in 2017. In addition to a robust drug portfolio, I strongly believe that Pfizer also has one seriously ...
Pfizer Inc. (PFE) Closes 0.59% Up on the Day for February 24
Cadence Capital Management LLC Has $12623000 Position in Pfizer, Inc. (PFE)  Sports Perspectives
Ronald E. Blaylock Elected to Pfizer's Board of Directors
NEW YORK--(BUSINESS WIRE)--Pfizer Inc. today announced the election of Ronald E. Blaylock to its Board of Directors, effective immediately.
Pfizer Is A Solid Buy In 2017
Besides having a solid and well-diversified drug portfolio, Pfizer also boasts of having some of the most promising investigational therapies in its research pipeline.
EOD Risers: Pfizer Inc., Procter & Gamble Co, The Coca-Cola Co, Travelers ...
The stock price for Pfizer Inc. with EPIC code: (NYSE:PFE) a research-based global biopharmaceutical company, moved up 0.01% during yesterday's session.
Pfizer Subpoenaed in DOJ Investigation of Drugmaker Charity Connections
Last year, Gilead Sciences Inc., Biogen Inc. and Jazz Pharmaceuticals Plc said they had received subpoenas for documents related to the nonprofits.
Pfizer subpoenaed in US over patient assistance plans  Reuters
Pfizer Near A Technical Breakout
Pfizer's share price won't go to the moon but I believe there is strong downside protection here mainly due to the company's sheer size and diversification. I think what dividend investors need to take into account here is that there are companies ...
Pfizer Inc. (PFE) Closes Flat on the Day for February 17
Taking a Fresh Look at Pfizer Inc. (PFE)  StockNewsJournal
SIX Exchange Regulation Publishes Decision With Grounds Regarding Delisting Of ...
Pfizer Inc. has announced, that all of its secondary listed shares (Swiss Security Number 962'004 /ISIN US71170811035) with a nominal value of USD 0.05 will be delisted from SIX Swiss Exchange.
Pfizer, Inc. (PFE) Ex-Dividend Date Scheduled for February 01, 2017
Pfizer, Inc. ( PFE ) will begin trading ex-dividend on February 01, 2017. A cash dividend payment of $0.32 per share is scheduled to be paid on March 01, 2017.
Pfizer reveals easing of fourth quarter revenue  Proactive Investors USA & Canada
Pfizer's profit misses as vaccine sales lag, costs rise  CNBC